Skip to main content

Table 4 Toxicity Distribution

From: Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer

Toxicity Grade ACRT STRT1 STRT2 Total p-value
   (45 Gy) (60-63 Gy) (> 63 Gy)   
   n = 154 n = 99 n = 239   
Esophagitis 0-1 107(89.9%) 80(88.9%) 82(90.1%) 269(89.7%) 0.958
  ≥ 2 12(10.1%) 10(11.1%) 9(9.9%) 31(10.3%)  
Dysphagia 0-1 110(92.4%) 75(83.3%) 80(87.9%) 265(88.3%) 0.126
  ≥ 2 9(7.6%) 15(16.7%) 11(12.1%) 35(11.7%)  
Pneumonitis 0-1 105(88.2%) 71(78.9%) 71(78.0%) 247(82.3%) 0.093
  ≥ 2 14(11.8%) 19(21.1%) 20(22.0%) 53(17.7%)  
Radiation Dermatitis 0-1 117(98.3%) 79(87.8%) 78(85.7%) 274(91.3%) 0.002
  ≥ 2 2(1.7%) 11(12.2%) 13(14.3%) 26(8.7%)  
Nausea/Vomiting 0-1 115(96.6%) 79(87.8%) 87(95.6%) 281(93.7%) 0.022
  ≥ 2 4(3.4%) 11(12.2%) 13(14.3%) 26(8.7%)  
Weight loss 0-1 115(96.6%) 81(90.0%) 90(98.9%) 286(95.3%) 0.020
  ≥ 2 4(3.4%) 9(10.0%) 1(1.1%) 14(4.7%)